Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus

We sought to test whether vaccine-induced immune responses could protect rhesus macaques (RMs) against upfront heterologous challenges with an R5 simian-human immunodeficiency virus, SHIV-2873Nip. This SHIV strain exhibits many properties of transmitted HIV-1, such as tier 2 phenotype (relatively di...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Vaccine
Asıl Yazarlar: Lakhashe, Samir K., Byrareddy, Siddappa N., Zhou, Mingkui, Bachler, Barbara C., Hemashettar, Girish, Hu, Shiu-Lok, Villinger, Francois, Else, James G., Stock, Shannon, Lee, Sandra J., Vargas-Inchaustegui, Diego A., Cofano, Egidio Brocca, Robert-Guroff, Marjorie, Johnson, Welkin E., Polonis, Victoria R., Forthal, Donald N., Loret, Erwann P., Rasmussen, Robert A., Ruprecht, Ruth M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4343195/
https://ncbi.nlm.nih.gov/pubmed/25245933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.08.065
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller